Mucosal Microbiome in Human Gastric Intestinal Metaplasia and Duodenal Tissue.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02428426

Enrollment

Registered

2015-04-28

Start date

2014-09-30

Completion date

2015-07-31

Last updated

2015-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duodenum, Gastric Intestinal Metaplasia, Mucosal Microbiome

Keywords

Mucosal Microbiome, gastric intestinal metaplasia, duodenum

Brief summary

To investigate the mucosal microbiome in human gastric intestinal etaplasia and duodenal tissue.

Interventions

OTHERendomicroscopy, targeted biopsy and 16s rRNA gene sequencing

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Patients scheduled for gastroendoscopy examination Aged between 18 and 80 years old

Exclusion criteria

* Antibiotic, probiotic or prebiotic usage within 2months,gastric inhibitor usage within 1 month Esophageal, gastric or duodenal cancer or other malignancy History of upper GI tract surgery Coagulopathy or bleeding disorders Allergy to fluorescein sodium Pregnant or breast-feeding (for females) Impaired renal function

Design outcomes

Primary

Measure	Time frame
The operational taxonomy units in gastric Intestinal Metaplasia and and Duodenal mucosal microbiome	6 months

Countries

China

Contacts

Primary Contactli yanqing, PhD,MD

liyanqing@sdu.edu.cn86-531-82169236

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026